Bulgay, CelalBayraktar, IsikKazan, Hasan HuseyinYildirim, Damla SelinZorba, ErdalAkman, OnurErgun, Mehmet Ali2024-08-042024-08-0420232227-9032https://doi.org/10.3390/healthcare11050681https://hdl.handle.net/11616/101211The present study aimed to examine the vitamin D receptor (VDR), rs2228570 polymorphism, and its effect on elite athletes' performance. A total of 60 elite athletes (31 sprint/power and 29 endurance) and 20 control/ physically inactive, aged 18-35, voluntarily participated in the study. The International Association of Athletics Federations (IAAF) score scale was used to determine the performance levels of the athletes' personal best (PB). Whole exome sequencing (WES) was performed by the genomic DNA isolated from the peripheral blood of the participants. Sports type, sex, and competitive performance were chosen as the parameters to compare within and between the groups by linear regression models. The results showed no statistically significant difference between the CC, TC, and TT genotypes within and between the groups (p > 0.05). Additionally, our results underlined that there were no statistically significant differences for the association of rs2228570 polymorphism with PBs within the groups of the (p > 0.05) athletes. The genetic profile in the selected gene was similar in elite endurance, sprint athletes, and in controls, suggesting that rs2228570 polymorphism does not determine competitive performance in the analyzed athlete cohort.eninfo:eu-repo/semantics/openAccessathleticssprintpower athletesendurance athletesVDRrs2228570 polymorphismArticle1153690068810.3390/healthcare110506812-s2.0-85149708053Q2WOS:000947298900001Q2